Public filings / PRAX on Yahoo Finance (opens in a new tab)
PRAX: insider buying, 13F holders, analyst moves
Praxis Precision Medicines Inc - US
A summary of public filings about Praxis Precision Medicines Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold PRAX
Combined reported value $1.59B; 1 sold out since Q1 2026.
Holders among our 100 managers: 1 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Perceptive Advisors | $681.6M | 10.58% | Unchanged |
| Baker Bros. Advisors | $587.0M | 2.94% | Unchanged |
| Deerfield Company | $322.5M | 3.36% | Unchanged |
| Polen Capital | $2.4M | 0.02% | Trimmed |
| Tudor Investment | $731K | 0.00% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.